DKBmed Radio Podcast Por DKBmed arte de portada

DKBmed Radio

DKBmed Radio

De: DKBmed
Escúchala gratis

Acerca de esta escucha

 DKBmed Radio provides health care clinicians with expert insight and analysis in a wide variety of disease states and specialty areas. Earn continuing medical education (CME) credit by listening to the episode and visiting our website linked in the episode description. Visit https://dkbmed.com/ for more information and CME opportunities.

Hosted on Acast. See acast.com/privacy for more information.

DKBmed 2019 Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • Cystic Fibrosis Life Transitions

    Cystic Fibrosis Life Transitions
    Jul 3 2025
    Until the advent of highly effective CFTR modulator medications, cystic fibrosis was considered a pediatric disease, because most individuals did not survive into adulthood. Now, with more adults living with CF than children, priorities must change. In these interviews, we discuss what transitions to a longer life with CF entails: from pediatric to adult care; from the possibilities of motherhood and the need for family planning; from adulthood into older age and the infirmities common to all aging adults.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    13 m
  • New Directions in Long-Acting ART and Long-Acting PrEP

    New Directions in Long-Acting ART and Long-Acting PrEP
    Mar 28 2025

    How will the current research advancements in long-acting ART affect clinicians’ ability to provide better care for their patients with HIV? The recent data show that the low uptake and adherence to PrEP may be largely due to the pill burden and potential stigma of daily dosing. How might the newer longer-acting PrEP regimens challenge this reluctance?


    Post-test for CME credits: https://elit.dkbmed.com/issues/226/test

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    41 m
  • Barriers To Minority Participation in MS Clinical Trials

    Barriers To Minority Participation in MS Clinical Trials
    Mar 25 2025

    In the clinical trials of new MS medications and procedures, why has the participation of racial and ethnic minority individuals been so low? Is it a difficulty with outreach? Are the patient barriers to participation underrecognized and underaddressed? Does historical mistrust of the medical community remain a strong negative? What should clinicians and trial designers do to increase diversity to improve care for all individuals with MS?


    Take our post-test to claim CME credits (https://elit.dkbmed.com/issues/223/test)

    Read this podcast's companion newsletter here. (https://elit.dkbmed.com/issues/221)

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
    24 m
Todavía no hay opiniones